Related Experiment Videos
Minimal resection for bronchogenic carcinoma. An update.
M M Crabbe1, G A Patrissi, L J Fontenelle
1Department of Surgery/SCHSG, USAF Medical Center, Wright-Patterson AFB, Ohio 45433-5300.
Chest
|June 1, 1991
Summary
Minimal resection for early-stage lung cancer (bronchogenic carcinoma) offers survival and recurrence rates comparable to more extensive surgeries. This approach is a viable option for select patients unable to tolerate larger procedures.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Stage I bronchogenic carcinoma requires curative treatment.
- Extensive resections may not be feasible for all patients due to comorbidities.
- Minimal resection offers a less invasive surgical option.
Purpose of the Study:
- To evaluate the efficacy of minimal resection for stage I bronchogenic carcinoma.
- To compare survival and recurrence rates of minimal resection with those of more extensive resections.
Main Methods:
- Retrospective analysis of 24 patients with stage I bronchogenic carcinoma.
- Patients underwent minimal resection with curative intent over a 12-year period.
- Survival and recurrence rates were assessed with a median follow-up of 38 months.
Main Results:
- The five-year actuarial survival rate was 65%.
- Local recurrence rate was 13% (3/24), and distant recurrence rate was 17% (4/24).
- Outcomes were similar to reported rates for more extensive resections.
Conclusions:
- Minimal resection is an acceptable alternative treatment for selected patients with stage I bronchogenic carcinoma.
- This approach provides comparable survival and recurrence rates to more extensive surgeries.
- Patient selection is crucial for optimal outcomes in minimal resection for early-stage lung cancer.